Goldberg Mark Alan

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Goldberg Mark Alan
CIK #0001532475
EDGAR Form CIK 2011 - 2026
3 [0001532475]
4 [0001532475]
Form 3/4/5 Subject 2011 - 2026
Blueprint Medicines Corp
Goldberg Mark Alan
Crescent Biopharma Inc
ImmunoGen Inc
Idera Pharmaceuticals Inc
Audentes Therapeutics Inc
aTYR Pharma Inc
Synageva Biopharma Corp
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Blueprint Medicines Corp BPMC
Common Stock
2025-07-17 Tender 18,254
Blueprint Medicines Corp BPMC
Common Stock
2025-07-17 Disposed to issuer 3,902
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
2025-07-17 Disposed to issuer 4,570
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
2025-07-17 Disposed to issuer 5,300
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
2025-07-17 Disposed to issuer 5,300
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
2025-07-17 Disposed to issuer 4,500
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
2025-07-17 Disposed to issuer 4,500
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
2025-07-17 Disposed to issuer 4,875
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
2025-07-17 Disposed to issuer 10,909
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
2025-07-17 Disposed to issuer 7,500
Blueprint Medicines Corp BPMC
Common Stock
2025-06-18 Grant 3,902 $128.12 499,924
Blueprint Medicines Corp BPMC
Common Stock
2024-06-12 Grant 2,242 $0.00
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
2024-06-12 Grant 4,570 $0.00
Crescent Biopharma Inc GLYC
Stock Option (right to buy) · derivative
2024-05-01 Grant 40,000 $0.00
Crescent Biopharma Inc GLYC
Common Stock
2024-03-29 Grant 4,584 $3.00 13,752
ImmunoGen Inc IMGN
Stock Option (Right to Buy) · derivative
2024-02-12 Disposed to issuer 44,000
ImmunoGen Inc IMGN
Common Stock
2024-02-12 Disposed to issuer 60,720
ImmunoGen Inc IMGN
Restricted Stock Unit · derivative
2024-02-12 Disposed to issuer 13,090
ImmunoGen Inc IMGN
Deferred Share Unit · derivative
2024-02-12 Disposed to issuer 160,350
ImmunoGen Inc IMGN
Stock Option (Right to Buy) · derivative
2024-02-12 Disposed to issuer 19,597
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com